A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
May 2004
in “PubMed”
TLDR Finasteride may help some male chronic pelvic pain patients, but more research needed.
This study aimed to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (CPPS). The study involved 76 patients who were randomized to receive either finasteride or a placebo for 6 months. The results showed that although more patients had an improvement in the subjective overall assessment (SOA), total NIH-CPSI, and responder subgroups in the finasteride group than in the placebo group, the results were not statistically significant. Finasteride and placebo were generally well-tolerated. The study concluded that finasteride may benefit some patients with CPPS, but a larger, properly powered study is required to confirm any clinical benefit.
View this study on pubmed.ncbi.nlm.nih.gov →
Cited in this study
research A Prospective, 1-Year Trial Using Saw Palmetto Versus Finasteride in the Treatment of Category III Prostatitis/Chronic Pelvic Pain Syndrome
Finasteride improves chronic pelvic pain, saw palmetto doesn't.
research The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.
research The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients
Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.
research Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study
Finasteride didn't significantly improve ICPPS symptoms, more research needed.
Related
research A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
Finasteride may help some male chronic pelvic pain patients, but more research needed.